Cargando…
The Trypanosoma cruzi TcrNT2 Nucleoside Transporter Is a Conduit for the Uptake of 5-F-2′-Deoxyuridine and Tubercidin Analogues
Among the scarce validated drug targets against Chagas disease (CD), caused by Trypanosoma cruzi, the parasite’s nucleoside salvage system has recently attracted considerable attention. Although the trypanocidal activity of tubercidin (7-deazapurine) has long been known, the identification of a clas...
Autores principales: | Aldfer, Mustafa M., Alfayez, Ibrahim A., Elati, Hamza A. A., Gayen, Nilanjana, Elmahallawy, Ehab Kotb, Milena Murillo, Ana, Marsiccobetre, Sabrina, Van Calenbergh, Serge, Silber, Ariel M., de Koning, Harry P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693223/ https://www.ncbi.nlm.nih.gov/pubmed/36432150 http://dx.doi.org/10.3390/molecules27228045 |
Ejemplares similares
-
Phenotypic Evaluation of Nucleoside Analogues against Trypanosoma cruzi Infection: In Vitro and In Vivo Approaches
por: Fiuza, Ludmila F. de A., et al.
Publicado: (2022) -
Combining tubercidin and cordycepin scaffolds results in highly active candidates to treat late-stage sleeping sickness
por: Hulpia, Fabian, et al.
Publicado: (2019) -
Nucleoside Transport and Nucleobase Uptake Null Mutants in Leishmania mexicana for the Routine Expression and Characterization of Purine and Pyrimidine Transporters
por: Aldfer, Mustafa M., et al.
Publicado: (2022) -
Cloning and Characterization of Trypanosoma congolense and T. vivax Nucleoside Transporters Reveal the Potential of P1-Type Carriers for the Discovery of Broad-Spectrum Nucleoside-Based Therapeutics against Animal African Trypanosomiasis
por: Ungogo, Marzuq A., et al.
Publicado: (2023) -
First Total Synthesis of 5′-O-α-d-Glucopyranosyl Tubercidin
por: Ouyang, Wenliang, et al.
Publicado: (2020)